NO20080411L - Alkylsulfonamiddderivater - Google Patents
AlkylsulfonamiddderivaterInfo
- Publication number
- NO20080411L NO20080411L NO20080411A NO20080411A NO20080411L NO 20080411 L NO20080411 L NO 20080411L NO 20080411 A NO20080411 A NO 20080411A NO 20080411 A NO20080411 A NO 20080411A NO 20080411 L NO20080411 L NO 20080411L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- provides
- subject
- treating
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 6
- 239000003937 drug carrier Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 102100029549 Neuropeptide Y receptor type 5 Human genes 0.000 abstract 1
- 108010046593 Neuropeptide Y5 receptor Proteins 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 125000004422 alkyl sulphonamide group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15979405A | 2005-06-23 | 2005-06-23 | |
| PCT/US2006/024043 WO2007002126A1 (fr) | 2005-06-23 | 2006-06-21 | Alkylsulfamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080411L true NO20080411L (no) | 2008-01-22 |
Family
ID=37595447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080411A NO20080411L (no) | 2005-06-23 | 2008-01-22 | Alkylsulfonamiddderivater |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JP2008546787A (fr) |
| KR (1) | KR20080018206A (fr) |
| CN (1) | CN101203499A (fr) |
| AR (1) | AR054480A1 (fr) |
| AU (1) | AU2006262319A1 (fr) |
| BR (1) | BRPI0612270A2 (fr) |
| CA (1) | CA2613377A1 (fr) |
| EA (1) | EA200800111A1 (fr) |
| IL (1) | IL187894A0 (fr) |
| MX (1) | MX2007015998A (fr) |
| NO (1) | NO20080411L (fr) |
| TW (1) | TW200736237A (fr) |
| WO (1) | WO2007002126A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2650683A1 (fr) | 2006-04-28 | 2007-11-08 | Shionogi & Co., Ltd. | Derive amine ayant une activite antagoniste du recepteur y5 du npy |
| SA08290668B1 (ar) | 2007-10-25 | 2012-02-12 | شيونوجي آند كو.، ليمتد | مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها |
| US8227618B2 (en) | 2009-04-23 | 2012-07-24 | Shionogi & Co., Ltd. | Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof |
| CA2834429C (fr) | 2011-04-27 | 2019-07-02 | Kyohei Hayashi | Derive heterocyclique aromatique a cycle a 5 chainons ayant une activite antagoniste du recepteur npy y5 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989379B1 (en) * | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
-
2006
- 2006-05-22 TW TW095118082A patent/TW200736237A/zh unknown
- 2006-06-20 AR ARP060102605A patent/AR054480A1/es not_active Application Discontinuation
- 2006-06-21 AU AU2006262319A patent/AU2006262319A1/en not_active Abandoned
- 2006-06-21 BR BRPI0612270A patent/BRPI0612270A2/pt not_active IP Right Cessation
- 2006-06-21 EA EA200800111A patent/EA200800111A1/ru unknown
- 2006-06-21 CA CA002613377A patent/CA2613377A1/fr not_active Abandoned
- 2006-06-21 KR KR1020077030039A patent/KR20080018206A/ko not_active Withdrawn
- 2006-06-21 WO PCT/US2006/024043 patent/WO2007002126A1/fr not_active Ceased
- 2006-06-21 MX MX2007015998A patent/MX2007015998A/es not_active Application Discontinuation
- 2006-06-21 JP JP2008518334A patent/JP2008546787A/ja not_active Withdrawn
- 2006-06-21 CN CNA2006800222481A patent/CN101203499A/zh active Pending
-
2007
- 2007-12-04 IL IL187894A patent/IL187894A0/en unknown
-
2008
- 2008-01-22 NO NO20080411A patent/NO20080411L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200800111A1 (ru) | 2008-06-30 |
| TW200736237A (en) | 2007-10-01 |
| AR054480A1 (es) | 2007-06-27 |
| CA2613377A1 (fr) | 2007-01-04 |
| IL187894A0 (en) | 2008-03-20 |
| CN101203499A (zh) | 2008-06-18 |
| KR20080018206A (ko) | 2008-02-27 |
| AU2006262319A1 (en) | 2007-01-04 |
| WO2007002126A1 (fr) | 2007-01-04 |
| MX2007015998A (es) | 2008-03-07 |
| JP2008546787A (ja) | 2008-12-25 |
| BRPI0612270A2 (pt) | 2016-09-06 |
| WO2007002126A8 (fr) | 2007-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051048L (no) | Terapeutisk humant anti-IL-1R1 monoklonalt antistoff | |
| NO20091635L (no) | Sammensetninger og fremgangsmater for diagnostisering og behandling av kreft | |
| MA29427B1 (fr) | Antagonistes et leurs methodes d'utilisation | |
| MA29387B1 (fr) | Inhibiteurs de la dipeptidyl peptidase iv | |
| MX2010004454A (es) | Anti-proproteina convertasa subtilisina/kexina tipo 9 y metodos para tratar trastornos de lipidos y colesterol. | |
| EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
| NO20081772L (no) | Ikke-basiske antagonister av melaninkonsentrerende hormon-reseptor-1 | |
| MY169272A (en) | Her2 antibody composition | |
| ECSP099375A (es) | Derivados de azacicloalcanos como inhibidores de estearoil-coenzima a delta-9 desaturasa | |
| NO20053678L (no) | Kombinasjonsterapi for behandling av immuninflammatoriske forstyrrelser | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| WO2009050136A3 (fr) | Procédé de traitement du syndrome de cushing | |
| NO20083885L (no) | Fremgangsmate for behandling av inflammatoriske sykdommer | |
| WO2005120557A3 (fr) | Inhibition du recepteur proteique stimulant les macrophages (ron) | |
| TW200800979A (en) | Halogenated sulfonamide derivatives | |
| WO2010053861A3 (fr) | Amides biologiquement actifs | |
| WO2007095091A3 (fr) | Administration orale d'agents thérapeutiques utilisant des agonistes à jonctions serrées | |
| DK1296972T3 (da) | Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer | |
| NO20080411L (no) | Alkylsulfonamiddderivater | |
| NO20053838L (no) | Substituerte alkyl-amido-piperidiner | |
| DE602005014566D1 (de) | Chinolinon-carboxamid-verbindungen | |
| WO2008100563A3 (fr) | Compositions et méthodes pour diagnostiquer et traiter le cancer | |
| DK2101730T3 (da) | Galenisk form til transmucosal indgivelse af paracetamol | |
| WO2007114902A3 (fr) | Composés d'alkylthiobenzylpipéridine | |
| WO2004007430A3 (fr) | Nouveaux composes |